Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Ocular Therapeutix (OCUL) Interest Coverage Ratio: 2013-2025

Historic Interest Coverage Ratio for Ocular Therapeutix (OCUL) over the last 13 years, with Sep 2025 value amounting to -22.88.

  • Ocular Therapeutix's Interest Coverage Ratio fell 60.39% to -22.88 in Q3 2025 from the same period last year, while for Sep 2025 it was -20.72, marking a year-over-year decrease of 114.44%. This contributed to the annual value of -12.65 for FY2024, which is 74.13% down from last year.
  • As of Q3 2025, Ocular Therapeutix's Interest Coverage Ratio stood at -22.88, which was down 2.04% from -22.43 recorded in Q2 2025.
  • Over the past 5 years, Ocular Therapeutix's Interest Coverage Ratio peaked at -4.83 during Q4 2023, and registered a low of -22.88 during Q3 2025.
  • Over the past 3 years, Ocular Therapeutix's median Interest Coverage Ratio value was -13.64 (recorded in 2024), while the average stood at -13.84.
  • In the last 5 years, Ocular Therapeutix's Interest Coverage Ratio skyrocketed by 53.92% in 2023 and then crashed by 237.12% in 2024.
  • Ocular Therapeutix's Interest Coverage Ratio (Quarterly) stood at -10.74 in 2021, then rose by 2.43% to -10.48 in 2022, then spiked by 53.92% to -4.83 in 2023, then slumped by 237.12% to -16.28 in 2024, then tumbled by 60.39% to -22.88 in 2025.
  • Its Interest Coverage Ratio stands at -22.88 for Q3 2025, versus -22.43 for Q2 2025 and -21.42 for Q1 2025.